Corrigendum to “Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial” [Allergol Int 74 (2025) 274-82] by Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, Norihiro Harada, Yasunari Miyazaki, Hideki Katsura, Etsuko Tagaya, Junko Terada, Masayuki Hojo, Naoya Sugimoto, Hiroyuki Nagase, Yuta Kono, Hisato Hiranuma, Yasuhiro Gon, Ryo Takemura, Misato Irie, Reina Nakamura, Hiroki Kabata, Jun Miyata, Koichi Fukunaga

Get full text

Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial by Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, Norihiro Harada, Yasunari Miyazaki, Hideki Katsura, Etsuko Tagaya, Junko Terada, Masayuki Hojo, Naoya Sugimoto, Hiroyuki Nagase, Yuta Kono, Hisato Hiranuma, Yasuhiro Gon, Ryo Takemura, Misato Irie, Reina Nakamura, Hiroki Kabata, Jun Miyata, Koichi Fukunaga

Get full text

Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction by Toshihiro Shirai, Keita Hirai, Taisuke Akamatsu, Kenji Mizumura, Hitoshi Sasano, Norihiro Harada, Akihiko Tanaka, Hironori Sagara, Katsunori Masaki, Koichi Fukunaga, Konomi Kobayashi, Hiroyuki Nagase, Nobuaki Miyahara, Arihiko Kanehiro, Noboru Kitamura, Naruhiko Sugihara, Junko Terada-Hirashima, Masayuki Hojo, Kazuyuki Chibana, Etsuko Tagaya, Yasuhiro Gon

Get full text

Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo) by Hiroyuki Nagase, Konomi Kobayashi, Makiko Toma-Hirano, Maho Suzukawa, Norihiro Harada, Katsunori Masaki, Yoshito Miyata, Mayoko Tsuji, Junko Terada-Hirashima, Keiko Komatsuzaki, Hitoshi Sasano, Kenji Mizumura, Ryoji Kagoya, Yuya Shimizu, Shintaro Yoshihara, Norio Kihara, Yasunari Miyazaki, Toshiyuki Koya, Naruhiko Sugihara, Nobuhisa Ishikawa, Masayuki Hojo, Etsuko Tagaya, Akihiko Tanaka, Koichi Fukunaga, Yasuhiro Gon

Get full text

Elevated mepolizumab levels in patients with severe asthma responsive to 1 year’s mepolizumab treatment by Takayasu Nishimaki, MD, Hitoshi Sasano, MD, PhD, Sonoko Harada, PhD, Tomohito Takeshige, MD, PhD, Yuuki Sandhu, MD, PhD, Yuki Tanabe, MD, Kei Matsuno, MD, PhD, Tetsutaro Nagaoka, MD, PhD, Jun Ito, MD, PhD, Ryo Atsuta, MD, PhD, Mayu Ohuchi, PhD, Shigehiro Yagishita, MD, PhD, Akinobu Hamada, PhD, Kazuhisa Takahashi, MD, PhD, Norihiro Harada, MD, PhD

Get full text